Back to companies
PORTFOLIO
Gemma Biotherapeutics
GEMMABio, a new therapeutics company developing AAV based therapies, with a platform of new AAV serotypes, with a clinical pipeline focusing on pediatric monogenic diseases, and with a large preclinical pipeline for other large impact diseases.
Milestones
Founded: 2024 Invested: 2024
Leadership Team
James Wilson
HQ
Pennsylvania, USA
Earlybird Lead
WE INVEST BECAUSE
WE BELIEVE
Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.
